Zhengyu Liu
Immunology and Microbiology · The Ohio State University
Publications
108
Citations
1,747
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1996
This bibliographic record appears to combine work from multiple researchers sharing the name Zhengyu Liu, spanning cancer immunology, metabolism, hematopoiesis, and unrelated fields like climate reanalysis and electronics diagnostics. The immunology-related portion focuses on how metabolic factors (glucose, amino acids, metabolites) influence immune cells such as macrophages and T-cells in cancer, particularly in the context of tumor immune suppression and antitumor immunity. Because the topic scores are all listed as 0.00 and the publication list is highly heterogeneous, confidence in a single coherent research identity is limited.
Publication output has grown substantially over the last decade, rising from near zero in 2017-2019 to a peak of around 16-18 per year in 2022-2025, suggesting either a highly active and productive research profile or an aggregation of multiple same-named authors.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Long-Term Mortality and Cause-Specific Death after Non-Cardiac Chest Pain: A Multicentre Cohort Study of 160,245 Patients in China
SSRN Electronic Journal · 2026
- Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL
Cell · 2025
- Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy
Immunity · 2025
- Caffeine enhances antitumor T-cell activity by suppressing kynurenine pathway in colorectal cancer
Nature Communications · 2025
- A new last two millennium reanalysis based on hybrid gain analog offline EnKF and an expanded proxy database
npj Climate and Atmospheric Science · 2025
- Acetylation-induced degradation of ECHS1 enhances BCAA accumulation and proliferation in KRAS-mutant colorectal cancer
Journal of Experimental & Clinical Cancer Research · 2025
- Identifying potential drugs for treating Cardiovascular-kidney metabolic syndrome via reverse network pharmacology
Frontiers in Pharmacology · 2025
- Relation between serum magnesium and outcome in patients with Escherichia coli sepsis
BMC Infectious Diseases · 2025
- TransEHR: Alignment-free electronic health records continual learning across feature spaces
Expert Systems with Applications · 2025
- Intelligent faulty diagnosis on photovoltaic farm based on spatial attention mechanism and temporal convolutional network
Next research. · 2025
- ECG-I2S: a method for extracting heartbeat cycle and numerical signals from ECG captured images
Frontiers of Computer Science · 2025
- Author response: BCAS2 promotes primitive hematopoiesis by sequestering β-catenin within the nucleus
2025
- BCAS2 promotes primitive hematopoiesis by sequestering β-catenin within the nucleus
eLife · 2025
- Author response: BCAS2 promotes primitive hematopoiesis by sequestering β-catenin within the nucleus
2025
- BCAS2 promotes primitive hematopoiesis by sequestering β-catenin within the nucleus
eLife · 2025
- Figshare×7
- Aging×5
- SSRN Electronic Journal×4
- eLife×4
- Signal Transduction and Targeted Therapy×2
- Stephanie Schulte
Immunology and Microbiology · The Ohio State University
- Roman Covarrubias
Immunology and Microbiology · The Ohio State University
- Aparna Shinde
Medicine · Purdue University West Lafayette
- Gunjan Agarwal
Medicine · The Ohio State University
- Charles S. Umbaugh
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile